The selection and design of GPCR ligands: From concept to the clinic

Combinatorial Chemistry and High Throughput Screening

Volumn 7, Issue 5, 2004, Pages 441-452

  Ashton, Mark ^a   Charlton, Michael H ^a   Schwarz, Matthias K ^b   Thomas, Russell J ^a   Whittaker, Mark ^a  

^a EVOTEC UK LTD   (United Kingdom)

^b SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

GOLD; GPCR; Oxytocin; Pharmacophore; Preterm labour; Vasopressin; Virtual screening

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIGAND; OXYTOCIN ANTAGONIST; PEPTIDE LIBRARY; UNCLASSIFIED DRUG; VASOPRESSIN 1A RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

CLINICAL PROTOCOL; DRUG TARGETING; MOLECULAR BIOLOGY; MOLECULAR DOCKING; PHARMACOPHORE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SCORING SYSTEM; SCREENING; STRUCTURE ANALYSIS; VALIDATION PROCESS; VIRTUAL REALITY; VIRTUAL SCREENING;

EID: 4344702125     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/1386207043328607     Document Type: Review

References (60)

1. [l] Klabunde, T.; Hessler, G. ChemBioChem., 2002, 3, 928.
2. Horn, F.; Mokrane, M.; Beukers, M.W.; Horsch, S.; Bairoch, A.; Chen, W.; Edvardsen, O.; Campagne, F.; Vriend, G. Nucleic Acids Res., 1998, 26, 277.
3. Gaulton, A.; Attwood, T.K. Curr. Opin. Pharmacol., 2003, 3, l14.
4. Qian, B.; Soyer, O.S.; Neubig, R.R.; Goldstein, R.A. FEBS Lett., 2003, 554, 95.
5. Papasaikas, P.K.; Bagos, P.G.; Litou, Z.I.; Hamodrakas, S.J. SAR QSAR Environ. Res., 2003, 14, 413.
6. Lapinsh, M.; Gutcaits, A.; Prusis, P.; Post, C.; Lundstedt, T.; Wikberg, J.E.S. Prot. Sci., 2002, 11, 795.
7. Gunnarsson, I; Andersson, P.; Wikberg, J.; Lundstedt, T. J. Chemometrics, 2003, 17, 82.
8. Lapinsh, M.; Prusis, P.; Gutcaits, A.; Lundstedt, T.; Wikberg, J.E.S. Biochem. Biophys. Acta, 2001, 1525, 180.
9. Lapinsh, M.; Prusis, P.; Lundstedt, T.; Wikberg, J.E.S. Mol. Pharmacol., 2002, 61, 1465.
10. Lapinsh, M.; Prusis, P.; Mutule, I.; Mutulis, F.; Wikberg, J.E.S. J. Med. Chem., 2003, 46, 2572.
11. [l1] Hibert, M.F.; Trumpp-Kallmeyer, S.; Bruinvels, A.; Hoflack, J. Mol. Pharmacol., 1991, 40, 8.
12. Kajihara, A.; Komooka, H.; Kamiya, K.; Yoneda, T.; Yoneda, S.; Nakamura, M.; Shimizu, T.; Umeyama, H. J. Lipid Mediat. Cell Signal. 1994, 9, 185.
13. Henderson, R.; Baldwin, J.M.; Cesca, T.A.; Zemlin, F.; Beckmann, E.; Downing, K.H. J. Mol. Biol., 1990, 213, 899.
14. Flower, D.R. Biochem. Biophys. Acta, 1999, 1422, 207.
15. Müller, G. Curr. Med. Chem., 2000, 7, 861.
16. Ballesteros, J.; Palczewski, K. Curr. Opin. Drug Disc. Dev., 2001, 4, 561.
17. Archer, E.; Maigret, B.; Escrieut, C.; Pradayrol, L.; Fourmy, D. Trends Pharm. Sci., 2003, 24, 36.
18. Becker, O.M.; Shacham, S.; Marantz, Y.; Noiman, S. Curr. Opin. Drug Disc. Dev., 2003, 6, 353.
19. Moro, S.; Deflorian, F.; Spalluto, G.; Pastorin, G.; Cacciara, B.; Kim, S-K.; Jacobson, K.A. Chem. Commun., 2003, 2949.
20. Vangrevelinghe, E; Zimmermann, K; Schoepfer, J; Portmann, R; Fabbro, D; Furet, P. J. Med. Chem., 2003, 46, 2656.
21. Sarno, S.; De Moliner, E.; Ruzzene, M.; Pagano, M. A; Battistutta, R.; Bain, J.; Fabbro, D.; Schoepfer, J.; Elliott, M.; Furet, P.; Meggio, F.; Zanotti, G.; Pinna Lorenzo A. Biochem. J., 2003, 374, 639.
22. Jones, G; Willett, P; Glen, R.C.; Leach, A.R.; Taylor R. J. Mol. Biol., 1997, 267, 727. Cambridge Crystallographic Data Centre, http://www.ccdc.cam.ac. uk
23. Ewing, T.J.A.; Kuntz, I.D. J. Comput. Chem., 1997, 18, 1175.
24. Morris, G.M.; Goodsell, D.S.; Halliday, R.S.; Huey, R.; Hart, W.E.; Belew, R.K.; Olson, A.J. J. Comput. Chem., 1998,19, 1639.
25. Eldridge, M.E.; Murray, C.W.; Auton, C.R.; Paolini, G.V.; Mee, R.P. J. Comp.-Aided Mol. Des., 1997, 5, 425. Schrödinger Inc., http://www. schrodinger.com
26. Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G, J. Mol. Biol., 1996, 261, 727. Tripos Inc., http://www.tripos.com
27. Muegge, I.; Martin, Y.C. J. Med. Chem., 1999, 42, 791.
28. Wang, R.; Lai, L.; Wang, S. J Comp-Aided. Mol. Des., 2002, 16, 11.
29. Bohm, H.J. J. Comp-Aided Mol. Des., 1998, 12, 1.
30. Charifson, P.S.; Corkery, J.J.; Murcko, M.A.; Walters, W.P. J. Med. Chem., 1999, 42, 5100.
31. [31 ] Tripos Inc., http://www.tripos.com
32. Gehlhaar, D.K.; Verkhiver, G.M.; Rejto, P.A.; Sherman, C.J.; Fogel, D.B.; Fogel, L.J.; Freer, S.T. Chem. Biol, 1995, 2, 317.
33. Mortenson, P.N.; Charlton, M.H. "Structure-based virtual screening: case study - HIV protease" presented at "Structure-Based Drug Design", Boston, April 2003.
34. Accelrys Inc., http://www.accelrys.com
35. CCG Inc., http://www.chemcomp.com
36. Jones, G.; Willett, P.; Glen, R.C. J. Comp.-Aided Mol. Design, 1995, 9, 532.
37. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Adv. Drug Delivery Res., 1997, 23, 3.
38. Oprea, T,I.; Davis, A.M.; Teague, S.J.; Leeson, P.D. J. Chem. Inf. Comput. Sci., 2001, 41, 1308.
39. Veber, D.F.; Johnson, S.F.; Cheng, H.-Y.; Smith, B.R.; Ward, K.W.; Kopple, K.D. J. Med. Chem., 2002, 45, 2615.
40. Schneider, G.; Neidhart, W.; Ciller, T.; Schmid, G. Angew. Chemie Int. Ed., 1999, 38, 2894.
41. Hall, L.H.; Mohney; B.; Kier, L.B. Quant. Struc-Act. Relat., 1991, 10, 43.
42. Pearlmann, R.S.; Smith, K.M. Perspectives Drug Disc. Des., 1998, 9/10/11, 339.
43. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B.A.; Le Trong, I.; Teller, D.C.; Okada, T.; Stenkamp, R.E.; Yamamoto, M.; Miyano, M. Science, 2000, 289, 739.
44. Bissantz, C.; Bernard, P.; Hibert, M.; Rognan, D, Proteins, 2003, 50, 5.
45. Evers, A.; Klebe, G. Angew. Chem. Int Ed., 2004, 43, 248.
46. Gohlke, H.M.; Hendlich, K; Klebe. G. J. Mol. Biol., 2000, 295, 337.
47. Varady, J.; Wu, X.; Fang, X.; Min, J.; Hu, Z.; Levnt, B.; Wang S. J. Med. Chem., 2003, 46, 4377.
48. Flohr, S.; Kurz, M.; Kostenis, E.; Brkovich, A.; Fournier, A.; Klabunde, T. J. Med. Chem., 2002, 9, 1799.
49. Koide, Y.; Hasegawa, T.; Takahashi, A.; Endo, A.; Mochizuki, N.; Nakagawa, M.; Nishida, A. J. Med. Chem., 2002, 45, 4629.
50. Jain, A.N. J. Med. Chem., 2004, 47, 947.
51. Balakin, K.V.; Tkachenko, S.E.; Lang, S.A.; Okun, I.; Ivanschenko, A.A.; Savchuk, N.P. J. Chem. Inf. Comput. Sci., 2002, 42, 1332.
52. Balakin, K.V.; Lang, S.A.; Skorenko, A.V.; Tkachenko, S.E.; Ivanschenko, A.A.; Savchuk, N.P. J. Chem. Inf. Comput. Sci., 2003, 43, 1553.
53. Schneider, G.; Nettekoven, M. J. Comb. Chem., 2003, 5, 233.
54. Gribbon, P.; Schaertl, S.; Wickenden, M.; Williams, G.; Grimley, R.; Stuhmeier, F.; Preckel, H.; Eggeling, C.; Kraemer, J.; Everett, J.; Keighley, W.W.; Sewing, A. Curr. Drug. Dis. Tech., 2004, 1, 27.
55. Zuckermann, R.N.; Martin, E.J.; Spellmeyer, D.C.; Stauber, G.B.; Shoemaker, K.R.; Kerr, J.M.; Figliozzi, G.M.; Goff, D.A.; Siani, M.A.; Simon, R.J.; Banville, S.C.; Brown, E.G.; Wang, L.; Richter, L.S.; Moos, W.H. J. Med. Chem., 1994, 37, 2678.
56. Schwarz, M.K..; Quattropani, A.; Page, P.; Thomas, R.J.; Baxter, A.; Dorbais, J.; Pomel, V.; Maio, M.; Mannino, C.; Covini, D.; Pittet, P.; Jorand-Lebrun, C.; Valognes, D.; Halazy, S.; Scheer, A.; Missotten, M,; Ayala, G.; Cirillo, R,; Tos, E.G.; Marinelli, P.; Giacchetti, C; Barberis, C.; Chollet, A. Abstracts of Papers, 226th ACS National Meeting, New York, NY, United States, September 2003, MEDI-370.
57. Cirillo, E.; Tos, E.G.; Schwarz, M.K.; Quattropani, A.; Scheer, A.; Missotten, M.; Dorbais, J.; Nichols, A.; Borrelli, F.; Giachetti, C.; Golzio, L.; Marinelli, P.; Thomas, R.J.; Chevillard, C.; Laurent, F.; Portet, K.; Barberis, C.; Chollet, A. J. Pharmacol. Exp. Ther., 2003, 306, 253.
58. Schwarz, M.K.; Page, P. Current Medicinal Chemistry, 2003, 10, 1441.
59. Smith, R.A.; Bobko, M.A.; Lee, W. Bioorg. Med. Chem. Lett., 1998, 8, 2369.
60. Bondensgaard, K.; Ankersen, M.; Thorgersen, H.; Hansen, B.S.; Wulff, B.S.; Bywater, R.P. J. Med. Chem., 2004, 47, 888.